About
Plant-based Psoriasis Therapy
Ullman Medical has identified and developed a novel botanical extract that demonstrated positive human clinical data in treating psoriasis. Pre-clinical evidence also showed non-toxic, anti-angiogenesis properties that may be effective in the treatment of eye diseases, arthritis, and certain cancers. The companys objective is the commercialization of this plant-based compound for the topical treatment of psoriasis and development of a therapeutic platform for the treatment of numerous immune-deficient diseases. Psoriasis remains a chronic skin disease with few safe, effective topical treatments.
Identity
| Name | Ullman Medical |
|---|---|
| Slug | ullman-medical1 |
| Type / kind | startup |
| Crunchbase ID | ullman-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7fv7MKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Mar 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Petah Tikva |
| HQ address | Petah Tikva, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business models
B2B
Tags
stealthmodebiotechnologyeye-diseasespharmaceuticalspatent-pendingdermatologytreatmentscancertopical-treatment
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}